Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07UKT
|
|||
| Drug Name |
ALRN-6924
|
|||
| Indication | Haematological malignancy [ICD-11: 2B33.Y] | Phase 2 | [1] | |
| Acute myeloid leukaemia [ICD-11: 2A60] | Phase 1 | [1] | ||
| Myelodysplastic syndrome [ICD-11: 2A37; ICD-9: 238.7] | Phase 1 | [1] | ||
| Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | ||
| Company |
Aileron Therapeutics Cambridge, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Anti-ageing pipeline starts to mature.Nat Rev Drug Discov. 2018 Sep;17(9):609-612. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.